UPMC deploys Elekta Neuromag MD MEG

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The University of Pittsburgh Medical Center (UPMC) has acquired Elekta Inc.'s Neuromag MD MEG (magnetoencephalography) device for registration and localization of neural activity both for brain research and clinical practice.

The real-time, millisecond mapping of neuronal activities throughout the brain provided by Elekta Neuromag MD MEG holds the promise for better diagnosis and treatment of functional brain disorders, such as epilepsy. MEG technology is used for pre-surgical mapping of the brain. One exciting area of research is defining the epileptogenic zone from which the seizure emanates

"With MEG, we are, for the first time, able to precisely and in real-time locate and quantitatively correlate neuronal activity in different areas of the brain," said L. Dade Lunsford, MD, chairman of the Department of Neurological Surgery and Director of the Center for Image-Guided Neurosurgery. "This precise, real-time monitoring of the brain will increase our understanding of how the brain functions and provide precise mapping of functional disorders. With improved understanding of the physiology of the brain, we will be in a better position to explore potential new treatment modalities," Dr Lunsford added.

UPMC has a long history of leadership in the field of non-invasive brain surgery and research. The center was the first clinical Gamma Knife center in the U.S. and recently became the first in the world to have three operating Gamma Knife units.